Trial Profile
An Open-label, Randomized, Multi-center, Crossover Study to Observe the Effect of Once-daily Mirapex ER(R) and Twice-daily Mirapex ER(R) in Patients With Parkinson Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 31 Jan 2012 New trial record